cbdMD Acquires Twinlab Brand Portfolio in $30 Million Deal

Key Facts

1cbdMD announced the acquisition of Twinlab's brands for a total of $30 million.

In a move reflecting the ongoing consolidation within the healthcare sector, cbdMD has announced the acquisition of Twinlab's brand portfolio. According to reports, the deal is valued at $30 million in revenue terms. This strategic acquisition is designed to bolster cbdMD's market presence and diversify its product offerings by integrating Twinlab's established brands into its operations.

This transaction occurs as companies in the healthcare and consumer finance space seek strategic growth through asset integration. Based on analyst assessments, the acquisition of these established brands is considered a bullish development for a mid-cap company, likely providing a significant boost to both revenue and overall market share.

As of September 2, 2026, specific instrument prices for the entities involved are currently unavailable in the market data. Investors will be watching for the long-term integration results of this $30 million deal, particularly following recent US economic data which showed Core PCE inflation holding steady at 3.3% as of late August.